Literature DB >> 21701038

Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.

Gilda Rechichi1, Stefania Galimberti, Mauro Signorelli, Cammillo Talei Franzesi, Patrizia Perego, Maria Grazia Valsecchi, Sandro Sironi.   

Abstract

OBJECTIVE: The objective of our study was to investigate whether apparent diffusion coefficient (ADC) values of endometrial cancer differ from those of normal endometrium and myometrium and whether they vary according to histologic tumor grade, the depth of myometrial invasion, or lymph node status. SUBJECTS AND METHODS: Seventy patients with histologically proved endometrial cancer and 36 control subjects with normal endometrium were enrolled in this prospective study. T2-weighted, dynamic T1-weighted, and diffusion-weighted images with b values of 0 and 1000 s/mm(2) were obtained of all patients. The ADC values of endometrial cancer, normal endometrium, and normal myometrium were recorded. Tumor grade, the depth of myometrial invasion, and lymph node status were assessed at postoperative histopathologic analysis.
RESULTS: The mean (± SD) ADC value (10(-3) mm(2)/s) of endometrial cancer (0.77 ± 0.12) was significantly lower than that of normal endometrium (1.31 ± 0.11, p < 0.0001) and normal myometrium (1.52 ± 0.21, p < 0.0001), with no overlap between the two former distributions. There was no significant difference between ADC values of endometrial cancer tissue in patients with tumor grade 1 (0.79 ± 0.08, n = 14), grade 2 (0.76 ± 0.14, n = 40), or grade 3 (0.75 ± 0.12, n = 16) (p = 0.67); in patients with deep (0.77 ± 0.13, n = 18) and those with superficial (0.76 ± 0.12, n = 52) myometrial invasion (p = 0.87); and in patients with (0.78 ± 0.10, n = 6) and those without (0.75 ± 0.14, n = 39) lymph node metastases (p = 0.64).
CONCLUSION: ADC values allow normal endometrium to be differentiated from endometrial carcinoma; however, they do not correlate with histologic tumor grade, the depth of myometrial invasion, or whether lymph node metastases are present.

Entities:  

Mesh:

Year:  2011        PMID: 21701038     DOI: 10.2214/AJR.10.5584

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  27 in total

1.  Quantitative assessment of diffusion kurtosis imaging depicting deep myometrial invasion: a comparative analysis with diffusion-weighted imaging.

Authors:  Jia-Cheng Song; Shan-Shan Lu; Jing Zhang; Xi-Sheng Liu; Cheng-Yan Luo; Ting Chen
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

Review 2.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

3.  Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Authors:  Priya Bhosale; Jingfei Ma; Revathy Iyer; Preetha Ramalingam; Wei Wei; Pamela Soliman; Michael Frumovitz; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

4.  ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer.

Authors:  Gilda Rechichi; Stefania Galimberti; Matteo Oriani; Patrizia Perego; Maria Grazia Valsecchi; Sandro Sironi
Journal:  Eur Radiol       Date:  2012-07-21       Impact factor: 5.315

5.  Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade.

Authors:  Stephanie Nougaret; Caroline Reinhold; Shaza S Alsharif; Helen Addley; Jocelyne Arceneau; Nicolas Molinari; Boris Guiu; Evis Sala
Journal:  Radiology       Date:  2015-04-30       Impact factor: 11.105

6.  Can magnetic resonance spectroscopy differentiate endometrial cancer?

Authors:  Jie Zhang; Shifeng Cai; Changzhong Li; Xichao Sun; Xue Han; Chunrun Yang; Caixia Fu; Qingwei Liu; Yinghui Xin; Yuanyuan Zong
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

7.  Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and Prognosis.

Authors:  Ichiro Yamada; Naoyuki Miyasaka; Daisuke Kobayashi; Kimio Wakana; Noriko Oshima; Akira Wakabayashi; Junichiro Sakamoto; Yukihisa Saida; Ukihide Tateishi; Yoshinobu Eishi
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

8.  Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI.

Authors:  Bin Yan; Xiufen Liang; Tingting Zhao; Chen Niu; Caixia Ding; Wenjun Liu
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

9.  Application of FLASH-3D dynamic contrast-enhanced imaging for diagnosis of endometrial carcinoma.

Authors:  Lixin Du; Xiaohu Li; Xixiong Qiu; Xiaolei Liu; Yuli Wang; Yongqiang Yu
Journal:  Br J Radiol       Date:  2016-07-26       Impact factor: 3.039

10.  Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence.

Authors:  Ingfrid S Haldorsen; Renate Grüner; Jenny A Husby; Inger J Magnussen; Henrica M J Werner; Oyvind O Salvesen; Line Bjørge; Ingunn Stefansson; Lars A Akslen; Jone Trovik; Torfinn Taxt; Helga B Salvesen
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.